| Visionflex Group Limited (VFX) ORDINARY FULLY PAID |
Health Care |
$8 |
Appendix 4C - Q2 FY26
|
23 Jan 2026 9:41AM |
$0.125 |
$0.093 |
fallen by
25.60%
|
|
VFX - Price-sensitive ASX Announcement
Full Release
Key Points
- Visionflex Group Limited's Appendix 4C report for Q2 FY26.
- Net cash outflows from operating activities: $290,000 for the quarter.
- Net cash outflows from operating activities: $1,289,000 year-to-date.
- Minimal investing activity with a $2,000 net outflow.
- Convertible debt securities raised $490,000 year-to-date.
- Convertible note facility with Adcock Private Equity.
- Potential interest renegotiation and equity conversion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Anteris Technologies Ltd (AVR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$127 |
Notification regarding unquoted securities - AVR
|
23 Jan 2026 9:41AM |
$8.910 |
$8.000 |
fallen by
10.21%
|
|
| OD6 Metals Limited (OD6) ORDINARY FULLY PAID |
Materials |
$11 |
Down Hole EM Survey Identifies Off Hole Conductors
|
23 Jan 2026 9:41AM |
$0.074 |
$0.053 |
fallen by
28.38%
|
|
OD6 - Price-sensitive ASX Announcement
Full Release
Key Points
- DHEM survey identifies strong off-hole conductors at Gulf Creek.
- Potential new drill target suggested by conductor proximity to historic copper workings.
- Strong conductor located 75m beyond end of hole GDD010 suggests fault offset.
- Six drill holes surveyed using four surface EM loops.
- OD6 Metals is fully permitted for 25 additional drill holes.
- DHEM survey results support high-priority target identification at depth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BlueScope Steel Limited (BSL) ORDINARY FULLY PAID |
Materials |
$12,709 |
Becoming a substantial holder
|
23 Jan 2026 9:41AM |
$30.420 |
$29.010 |
fallen by
4.64%
|
|
| Auris Minerals Limited (AUR) ORDINARY FULLY PAID |
Materials |
$44 |
Auris Approved to Commence Trading on OTCQB Exchange in USA
|
23 Jan 2026 9:39AM |
$0.042 |
$0.034 |
fallen by
19.05%
|
|
| Environmental Clean Technologies Limited (ECT) ORDINARY FULLY PAID |
Industrials |
$54 |
R&D Tax Incentive Rebate Received
|
23 Jan 2026 9:39AM |
$0.150 |
$0.130 |
fallen by
13.33%
|
|
ECT - Price-sensitive ASX Announcement
Full Release
Key Points
- R&D Tax Incentive rebate received: $556,698
- Eligible research activities receive a 43.5% rebate
- AusIndustry manages the R&D Tax Incentive program
- Rebate provided as cash when the company incurs a tax loss
- Tax offset provided when there is taxable income
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atomo Diagnostics Limited (AT1) ORDINARY FULLY PAID |
Health Care |
$32 |
Atomo Investor Webinar Presentation
|
23 Jan 2026 9:38AM |
$0.036 |
$0.039 |
risen by
8.33%
|
|
| Mayfield Group Holdings Limited (MYG) ORDINARY FULLY PAID |
Industrials |
$293 |
Mayfield Acquires Strategic Property
|
23 Jan 2026 9:37AM |
$2.990 |
$2.570 |
fallen by
14.05%
|
|
MYG - Price-sensitive ASX Announcement
Full Release
Key Points
- $8.4 million acquisition of 10,410m² industrial property adjacent to BE Switchcraft
- $240,000 annual savings through lease termination and reduced project leasing costs
- Debt-funded acquisition preserving $16.3 million cash reserves
- Immediate operational benefits through shared resources and reduced logistics
- Supports expansion in data center, renewable energy, and defense sectors
- $30 million in recent contract wins across various sectors
- Strategic acquisition aligning with core market momentum
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Visionflex Group Limited (VFX) ORDINARY FULLY PAID |
Health Care |
$8 |
Quarterly Activity Report - Q2 FY26
|
23 Jan 2026 9:37AM |
$0.125 |
$0.093 |
fallen by
25.60%
|
|
VFX - Price-sensitive ASX Announcement
Full Release
Key Points
- Customer cash receipts increased by 22% to $1 million.
- Operating cash outflow improved to $0.3 million.
- Unaudited revenue decreased by 12% to $0.8 million.
- Annual Recurring Revenue (ARR) increased by 23% to $1.95 million.
- Second-year subscription renewal secured with RFDS Victoria.
- Ongoing platform enhancements for improved interoperability.
- Focus on expanding recurring revenue and strategic partnerships.
- Aiming for revenue growth in the second half of FY26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Coast Entertainment Holdings Limited (CEH) ORDINARY FULLY PAID |
Consumer Discretionary |
$212 |
First Half FY26 Results - webcast and teleconference details
|
23 Jan 2026 9:37AM |
$0.560 |
$0.545 |
fallen by
2.68%
|
|
| Anteris Technologies Ltd (AVR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$127 |
Strategic Investment from Medtronic-$US320M Aggregate Raises
|
23 Jan 2026 9:37AM |
$8.910 |
$8.000 |
fallen by
10.21%
|
|
AVR - Price-sensitive ASX Announcement
Full Release
Key Points
- Anteris Technologies received a strategic investment of $US 90 million from Medtronic.
- This investment is part of a $US 320 million aggregate capital raise.
- The funds will support the global pivotal PARADIGM trial and commercialization of the DurAVR® Transcatheter Heart Valve (THV).
- The PARADIGM trial is a randomized controlled trial comparing DurAVR® THV with existing TAVRs.
- Medtronic's investment aligns with advancing transcatheter aortic valve replacement (TAVR) innovation.
- DurAVR® THV features biomimetic design using ADAPT® tissue technology.
- The collaboration may expand into other strategic areas in the future.
- Anteris is committed to improving the lives of patients with aortic stenosis.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Evion Group NL (EVG) ORDINARY FULLY PAID |
Materials |
$16 |
Change of Directors Interest Notice
|
23 Jan 2026 9:36AM |
$0.030 |
$0.028 |
fallen by
6.67%
|
|
| RareX Limited (REE) ORDINARY FULLY PAID |
Materials |
$29 |
Trading Halt
|
23 Jan 2026 9:36AM |
$0.034 |
$0.024 |
fallen by
29.41%
|
|
REE - Price-sensitive ASX Announcement
Full Release
Key Points
- RareX Limited requested a trading halt on 23 January 2026.
- The halt is pending a capital raising announcement.
- The trading halt will last until 28 January 2026 or the announcement release.
- RareX specializes in rare earths and other critical minerals.
- The company focuses on the Cummins Range and Mt Mansbridge projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Noviqtech Limited (NVQ) ORDINARY FULLY PAID |
Information Technology |
$10 |
Trading Halt
|
23 Jan 2026 9:35AM |
$0.023 |
$0.029 |
risen by
26.09%
|
|
NVQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Noviqtech Limited requests a trading halt on ASX.
- Trading halt is related to a proposed acquisition and capital raising.
- The halt is effective until the announcement is made or until 28 January 2026.
- No known issues to prevent the halt from being granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Riversgold Limited (RGL) ORDINARY FULLY PAID |
Materials |
$37 |
Response to ASX Aware Query
|
23 Jan 2026 9:34AM |
$0.018 |
$0.016 |
fallen by
11.11%
|
|
RGL - Price-sensitive ASX Announcement
Full Release
Key Points
- Riversgold Limited received exploration results in two batches on 7 and 16 January 2026.
- The company conducted a $2 million capital raising through issuing 200 million shares at $0.01 each.
- RGL asserts compliance with ASX Listing Rule 3.1 regarding continuous disclosure obligations.
- The exploration results and capital raising were anticipated to have a material effect on the company's securities.
- RGL ensured the confidentiality of data by adhering to internal management protocols.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lincoln Minerals Limited (LML) ORDINARY FULLY PAID |
Materials |
$39 |
Lincoln identifies historic high-grade copper targets
|
23 Jan 2026 9:33AM |
$0.016 |
$0.015 |
fallen by
6.25%
|
|
LML - Price-sensitive ASX Announcement
Full Release
Key Points
- Lincoln identified historic high-grade copper targets at Southern Eyre Project.
- Copper prospects showed results up to 11.1% Cu and 0.6g/t Au.
- Focus on Minbrie Project with confirmed copper mineralisation over 20km.
- Planning further exploration and drilling in the financial year 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BPM Minerals Limited (BPM) ORDINARY FULLY PAID |
Materials |
$31 |
High-Grade gold intersected at Beachcomber
|
23 Jan 2026 9:33AM |
$0.260 |
$0.275 |
risen by
5.77%
|
|
BPM - Price-sensitive ASX Announcement
Full Release
Key Points
- BPM Minerals completed a 3,180m, 24-hole RC drilling program at the Beachcomber Prospect.
- The drilling program confirmed Beachcomber as a high-grade gold system with multiple significant gold intercepts.
- High-grade intercepts include 9m at 7.77 g/t Au from 75m, and 6m at 6.72 g/t Au from 28m, among others.
- A newly defined south-plunging high-grade ore shoot was identified, open at depth.
- The project is part of the Forelands Gold Project, located in the Albany Fraser Orogen, Western Australia.
- Mineralisation at Beachcomber is associated with stacked quartz vein systems within quartz–feldspar gneiss.
- The Beachcomber Prospect has historical high-grade drill results dating back to 2006 by AngloGold Ashanti.
- BPM plans to continue drilling in late February/March 2026 to further explore the open mineralisation.
- The company is advancing approvals and permits for further exploration activities across its tenements.
- The Forelands Project includes other prospects such as Bonnie & Clyde with a significant gold-in-soil anomaly.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rhythm Biosciences Limited (RHY) ORDINARY FULLY PAID |
Health Care |
$78 |
Quarterly Activities Report and Appendix 4C
|
23 Jan 2026 9:33AM |
$0.160 |
$0.240 |
risen by
50%
|
|
RHY - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash outflow from operating activities: $306,000
- Receipt of $1.5 million from Research and Development Incentive
- Focus on commercialisation of ColoSTAT® test
- Enhancements in geneType™ platform
- Reduction in cash and cash equivalents but plans for equity financing
- Validation of genetic risk assessment in collaboration with Harvard
- Strategic partnerships for test commercialization
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| American Rare Earths Limited (ARR) ORDINARY FULLY PAID |
Materials |
$230 |
Application for quotation of securities - ARR
|
23 Jan 2026 9:32AM |
$0.430 |
$0.400 |
fallen by
6.98%
|
|
| Euroz Hartleys Group Limited (EZL) ORDINARY FULLY PAID |
Financials |
$209 |
Dividend/Distribution - EZL
|
23 Jan 2026 9:32AM |
$1.270 |
$1.270 |
fallen by
0%
|
|
| Galan Lithium Limited (GLN) ORDINARY FULLY PAID |
Materials |
$440 |
Initial Director's Interest Notice
|
23 Jan 2026 9:30AM |
$0.440 |
$0.355 |
fallen by
19.32%
|
|
| Ovanti Limited (OVT) ORDINARY FULLY PAID |
Communication Services |
$16 |
Cleansing Notice
|
23 Jan 2026 9:29AM |
$0.002 |
$0.002 |
fallen by
0%
|
|
| Anteris Technologies Ltd (AVR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$127 |
Closing of $US 230M Public Offering
|
23 Jan 2026 9:29AM |
$8.910 |
$8.000 |
fallen by
10.21%
|
|
AVR - Price-sensitive ASX Announcement
Full Release
Key Points
- Anteris Technologies closes $US 230 million public offering.
- Offering includes 40,000,000 shares at $US 5.75 each.
- Private placement with Medtronic involves 15,652,173 shares.
- Gross proceeds from activities total approximately $US 320 million.
- Funds to support DurAVR® THV global trial and manufacturing expansion.
- DurAVR® THV uses FDA-cleared ADAPT® tissue technology.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Celsius Resources Limited (CLA) ORDINARY FULLY PAID |
Materials |
$75 |
MCB Definitive Feasibility Study confirms stronger economics
|
23 Jan 2026 9:29AM |
$0.020 |
$0.023 |
risen by
15%
|
|
CLA - Price-sensitive ASX Announcement
Full Release
Key Points
- MCB project highlights a pre-tax NPV of USD 1.3 billion and an IRR of 31%.
- Post-tax NPV is USD 771 million with an IRR of 24%.
- Early cash flow driven by low C1 cash cost of USD 0.41/lb Cu in the first 10 years.
- The project has a 35-year mine life with significant mineral resources.
- Sublevel open stoping with paste backfill is the chosen mining method.
- Potential for expansion and increased throughput identified.
- Aims to secure offtake agreements in Asia for clean copper-gold concentrates.
- Plans to progress towards a final investment decision.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mitchell Services Limited (MSV) ORDINARY FULLY PAID |
Materials |
$93 |
FY26 Q2 quarterly result briefing
|
23 Jan 2026 9:28AM |
$0.350 |
$0.440 |
risen by
25.71%
|
|
Call 1300 880 160
Start a chat
Schedule a call
